LRRK2 and Parkinson disease: Mutations in leucine-rich repeat kinase 2 (LRRK2) have been linked to autosomal familial and sporadic PD [1], [2] and LRRK2 has recently been pursued as a potential therapeutic target for PD [3], [4], [5].